OpenAI has cut the size of its latest funding round by a third. According to the Financial Times, relayed by Reuters on Friday, October 30, 2026, the ChatGPT maker now wants to raise $20 billion at a $1.25 trillion valuation. Last month the target was $30 billion at $1.4 trillion. The change lands as US tech stocks suffered a rout over worries about the scale of AI spending, and it is the clearest sign yet that the market’s appetite for frontier-lab paper has limits.
The timing matters as much as the numbers. OpenAI had been racing to lock in commitments ahead of rival Anthropic’s anticipated public market debut in mid-November, a listing we covered in our look at Anthropic’s IPO and its Big Tech backers. The revised OpenAI target suggests the race has turned from a sprint for capital into a negotiation over price. This analysis walks through what was reported, what remains unconfirmed, and what the repricing means for AI funding in the weeks ahead.
What the FT Reported on October 30
The core facts are short. OpenAI is now seeking about $20 billion, down $10 billion from the $30 billion it had said it was aiming for. The valuation attached to the round dropped from $1.4 trillion to $1.25 trillion, a $150 billion haircut. Reuters had reported on October 19 that OpenAI was targeting $30 billion at $1.4 trillion, and it framed the push as an attempt to move quickly before Anthropic’s IPO.
Reuters, summarizing the FT report, added a detail that explains the cut. OpenAI had set a Friday deadline for investors to commit. By that deadline, some investors had trimmed their allocations, and the “first close” of the round was expected to raise less than $20 billion. So the $20 billion figure is a ceiling for the headline target, not a guarantee of cash in the bank. Reports of the first close point to a smaller initial haul.
One aggregator summary of the FT piece said SoftBank’s commitment had shrunk from $30 billion to $20 billion. We could not confirm that figure against a primary report, so treat it as unverified. OpenAI has not, in the coverage we reviewed, published its own statement on the revised terms.
| Term | Earlier target (Reuters, Oct. 19) | Revised target (FT, Oct. 30) | Change |
|---|---|---|---|
| Amount sought | $30 billion | $20 billion | -$10 billion (about -33%) |
| Valuation | $1.4 trillion | $1.25 trillion | -$150 billion (about -11%) |
| Raise as share of valuation | About 2.1% | About 1.6% | Smaller slice sold |
| Investor deadline | Not stated | Friday, Oct. 30 | Set by OpenAI |
| First close | Not stated | Expected below $20 billion | Some allocations reduced |
The percentage rows are our arithmetic on the reported figures, not numbers published by the FT. They show something useful: OpenAI is selling a smaller share of the company, at a lower price, to a thinner group of buyers.
The Tech Rout Behind the Cut
The market backdrop is stark. Reuters reported that the Nasdaq composite fell 2.9% on Friday, extending its decline to 7.8% from its record closing high on October 6. The one-day drop was the index’s largest since June 5, according to the same wire coverage. Separate market reports described a roughly $2 trillion wipeout in Nasdaq value during October, with CNN calling it the Nasdaq’s worst month in more than a year.
The trigger was a pair of earnings reports released late Thursday. Intel and Amazon both disappointed, and Amazon’s report pointed to still more AI spending while sales and profit missed analyst expectations. Our earlier coverage of the Nasdaq slide on Amazon and Intel and of Intel’s plunge on its Q4 outlook tracks how the selloff built across the week.
Reuters reported that Alphabet, Amazon, Meta and Microsoft have outlined plans to spend more than $740 billion in capital expenditures this year, a total Wall Street reads as AI infrastructure spending. Microsoft and SpaceX were the exceptions in that week’s earnings, with results suggesting AI spending was starting to pay off. That split is the heart of the problem for OpenAI. Investors are no longer treating every AI dollar the same way.
| Market datapoint | Figure | Source |
|---|---|---|
| Nasdaq composite move, Oct. 30 | -2.9% | Reuters |
| Decline from Oct. 6 record close | -7.8% | Reuters |
| Largest one-day drop since | June 5 | Reuters |
| October value wipeout | About $2 trillion | Reuters-based market reports |
| Four hyperscalers’ planned capex | More than $740 billion | Reuters |
Why a Smaller Round Is a Signal, Not a Collapse
It is tempting to read a $10 billion cut as distress. That reading goes too far. Raising $20 billion at $1.25 trillion would still rank among the largest private financings ever attempted, and the valuation is still far above where any other private AI lab traded a year ago. The reported move is a repricing, not a retreat.
What it does show is who holds the leverage. In a calm market, a company with OpenAI’s brand can name a number and let investors scramble. In a market that just lost roughly $2 trillion in a month, large allocators take a second look at position sizing, and even committed backers shave their checks. The FT’s account of trimmed allocations fits that pattern. A deadline that once pressured investors to move fast ended up exposing how many wanted to move less.
The narrower first close also reduces headline risk. A round that closes at a smaller size can be announced as oversubscribed against the new target, while a missed $30 billion target would have read as a failure. The cut, in that sense, protects the story OpenAI tells later.
The Anthropic IPO Factor
Reuters said OpenAI moved to secure investor commitments ahead of Anthropic’s anticipated public market debut in mid-November. The logic is plain. Once Anthropic lists, public-market investors get a live, priced comparison for a frontier lab, and that price will shape what every private round for a rival looks like. Raising before the listing locks in terms set by private negotiation, not by a ticker.
Aggregator coverage of the FT report said Anthropic is targeting a valuation of at least $1.5 trillion. That number came from secondary summaries, and we have not matched it to a primary filing, so we flag it as reported only. If accurate, it would put Anthropic’s target above OpenAI’s revised $1.25 trillion mark, a reversal of the order most observers assumed a year ago.
For OpenAI, that comparison is uncomfortable in a specific way. Private-round valuations are negotiated. A public listing is priced by a book of buyers on a single day. If the Anthropic book prices well in a falling market, OpenAI’s trimmed raise looks conservative. If it prices poorly, OpenAI’s decision to cut now will look prescient. Either outcome ties OpenAI’s valuation story to an event it does not control.
Who Is Funding the Frontier Labs
OpenAI is not the only AI name hunting for capital. Our reporting this month tracked Meta’s reported $97.5 billion equity raise for AI infrastructure and the squeeze on neoclouds, plus DeepSeek’s $16 billion round with 27% from state funds. Each tells a different version of the same story: the cost of training and serving frontier models now exceeds what operating cash flow can cover, so everyone is selling equity or debt.
| Player | Capital event (as reported) | Status |
|---|---|---|
| OpenAI | $20 billion at $1.25 trillion, cut from $30 billion at $1.4 trillion | First close expected under $20 billion |
| Anthropic | IPO anticipated mid-November, at least $1.5 trillion reported target | Pre-listing |
| Meta | Equity raise of about $97.5 billion reported | Reported, not final |
| DeepSeek | $16 billion round, 27% from state funds | Covered earlier on this site |
| Big Four hyperscalers | More than $740 billion planned capex this year | Guided in earnings |
The table makes the competitive picture visible. Four very different funding models are running in parallel: a private mega-round, a public listing, an equity raise by a cash-rich incumbent, and a state-backed round. The market is currently testing all four at once, and the October selloff is a price check on each.
Historical Context: Not the First Funding Wobble
OpenAI has faced conditional money before. In 2025, NBC News reported that a funding round could be cut by $10 billion if the company’s for-profit conversion did not occur by year-end. The headline figure is the same $10 billion, but the cause was structural then, not market-driven. This time the reduction follows a stock selloff, not a governance deadline.
Earlier in 2025, Benzinga reported that SoftBank might lead a $40 billion round at a $300 billion valuation, despite disruption from DeepSeek. The jump from that figure to a $1.25 trillion valuation now under discussion shows how fast expectations moved. A fourfold rise in roughly two years leaves little room for a market correction before the price starts to look stretched.
The pattern across both episodes is that OpenAI’s headline numbers have repeatedly been softened in the final stretch before closing. That does not make the company weak. It does mean readers should treat opening targets as negotiating positions and wait for closing figures.
What Investors Are Really Weighing
Three questions drive allocation decisions right now. First, how much of the AI spend turns into revenue? Microsoft’s report that spending was beginning to pay off drew a favorable reaction, while Amazon’s report of higher spending alongside misses did not. Second, how concentrated is the buyer base? A frontier lab that depends on a handful of strategic backers carries correlated risk. Third, what does the exit look like? With Anthropic heading toward a listing, investors can now ask where OpenAI’s own path to liquidity sits.
We could not verify OpenAI’s current revenue run rate or its compute commitments from primary reporting for this article, so we leave those figures out. A single outlet’s unconfirmed numbers are not a safe basis for sizing a trillion-dollar company. The public record that does hold up is the funding target, the valuation, the deadline and the market move.
Market Impact Across AI Supply Chains
A lab raising less money buys less compute. That chain reaction is what makes this story matter beyond OpenAI’s cap table. Chipmakers, memory suppliers, data center developers and cloud providers all price their expansion against the assumption that frontier labs will keep writing very large checks. A smaller raise does not break that assumption, but it nudges the pace.
Our earlier piece on the $750 billion Big Tech AI bet and slowing core growth framed the same tension from the spender’s side. The hyperscalers are guiding capex up while their core businesses grow more slowly, and the labs are asking investors for ever larger rounds. The October rout hit both ends of that chain in the same week.
Strategic investors sit in a special position. Companies that sell chips or cloud capacity to a lab often invest in that lab, which loops money back into their own revenue. Our report on Nvidia’s $3 billion investment in Meta shows the pattern in another corner of the industry. When a lab’s round shrinks, the revenue implied for its suppliers shrinks with it, and analysts will be recalculating those second-order effects through the weeks ahead.
OpenAI Versus Anthropic Versus the Open Challengers
The competitive comparison is lopsided in one respect: information. Anthropic is about to publish audited public-company disclosures, while OpenAI remains private and shares numbers selectively. DeepSeek raised money with state participation, which changes its incentives and its disclosure. Each model of funding produces a different kind of pressure.
On products, the field keeps moving. Our coverage of GPT-6.1 Terra and its $1 per million token pricing shows OpenAI still ships at pace, and aggressive token pricing is itself a sign of how competitive the market has become. Cheaper tokens help adoption but squeeze margins, which in turn raises the stakes of every funding round.
The honest read is that no one lab has a clean funding advantage. OpenAI has brand reach and a vast user base. Anthropic has the freshest path to public capital. DeepSeek has state backing. Meta and the hyperscalers have internal cash flows. The October selloff taxed all of them, and the OpenAI cut is simply the most visible receipt.
Five Predictions for the Next 60 Days
These are our own judgments, drawn from the reported facts. None come from named sources, and each could miss.
- The first close lands below $20 billion. The FT already said so, and a staged close with later tranches is the most natural way to reach the full target.
- OpenAI re-opens the round after Anthropic prices. A strong listing would let OpenAI go back to investors with a better comparison. A weak one would force more concessions.
- More allocators ask for structure. Expect tranches, milestones or protective terms to appear in place of straight common-style pricing.
- Hyperscaler capex guidance draws sharper questions. With more than $740 billion planned, analysts will push for evidence of returns on every call.
- Private AI valuations reset lower across the board. One lab’s repricing gives rivals’ investors a reason to ask for the same.
What Developers and Enterprise Buyers Should Do
For teams that build on OpenAI’s APIs, a smaller round is not a reason to panic. The company is not reported to be running out of money, and nothing in the FT account suggests service changes. It is a reason to review concentration risk. If a single model provider sits at the center of a product, keep a tested fallback and check contract terms on pricing and deprecation.
Procurement teams should also watch for pricing moves. Labs under funding pressure tend to push toward revenue, through usage tiers, enterprise bundles or price changes. Keep an eye on announcements in the next quarter and budget with some slack. Our AI and machine learning coverage tracks model releases and pricing as they land.
What We Still Do Not Know
Several points remain open. We do not know the final first-close amount, the identities of the investors who trimmed allocations, or whether the $1.25 trillion valuation holds in the final documents. Reports differ on some details, and where they did, we used the more conservative figure. For example, outlets quoted different Nasdaq index moves for Friday, so we used the Reuters composite figure of 2.9%.
We also have no verified quotes from OpenAI executives or investors on the revised terms, so none appear in this piece. If the company or its backers comment, the picture could shift quickly. Until then, the reported facts stand on their own: a lower target, a lower valuation, trimmed allocations, and a market that just had its roughest month in over a year.
The Takeaway
OpenAI’s cut from $30 billion to $20 billion, and from $1.4 trillion to $1.25 trillion, is a repricing forced by a falling market and a looming Anthropic listing. It is not proof the AI boom is over, but it shows the funding window can narrow within a single month. The next datapoints to watch are the first-close size, Anthropic’s debut in mid-November, and whether hyperscaler spending plans hold up under tougher questions.
FAQ
How much did OpenAI cut its funding target? The Financial Times reported, via Reuters, that OpenAI cut its target by $10 billion, from $30 billion to $20 billion.
What valuation is OpenAI seeking now? The reported valuation is $1.25 trillion, down from the $1.4 trillion it had sought earlier.
Why did OpenAI lower its target? The report ties the cut to a US tech selloff over AI spending worries, and says some investors reduced their allocations before a Friday commitment deadline. OpenAI has not published its own explanation in the coverage we reviewed.
How far did the market fall? Reuters reported the Nasdaq composite fell 2.9% on Friday, October 30, leaving it 7.8% below its October 6 record close.
What does this have to do with Anthropic? OpenAI was seeking commitments ahead of Anthropic’s anticipated public market debut in mid-November, according to Reuters. Anthropic’s listing will give investors a public price for a frontier lab.
Will this affect ChatGPT or the OpenAI API? Nothing in the reports points to service changes. Teams that depend on one provider should still keep a fallback plan and review contract terms.